What changed in 2026
Two things reshaped semaglutide access. First, the FDA approved an oral semaglutide tablet for weight management at the end of 2025 — the Wegovy pill — which launched in the US in early January 2026 in 1.5mg, 4mg, 9mg, and 25mg strengths.
Second, Novo Nordisk started selling directly to patients at $149/month for the pill and $199/month for the pen. Brand-name semaglutide at $149/month makes a lot of the “cheapest compounded semaglutide” advice written in 2024 and 2025 obsolete.
Our Picks
NovoCare Pharmacy
Why it's here: Novo Nordisk selling its own product directly with per-dose pricing published openly. FDA-approved semaglutide at a price that competes with compounded telehealth, with no membership fee and no ambiguity about what is in the vial.
Watch out for: You need your own prescriber. Pricing varies by dose — the price guide states $149 for the 1.5mg and 4mg doses and $199 for 0.25mg and 0.5mg — and the 4mg offer is published as running until August 31, 2026.
Read the full NovoCare Pharmacy review →Alloy
Why it's here: The lowest published compounded semaglutide price we found, prescribed by menopause-trained physicians who can consider hormone therapy alongside weight treatment. Unlimited messaging is included in the $99 care fee.
Watch out for: Designed for women in perimenopause and menopause. The $70 figure is medication only — your realistic all-in cost is around $169/month.
Read the full Alloy review →Mochi Health
Why it's here: Mochi publishes $99/month for every dose of compounded semaglutide from 0.22mg to 2.67mg weekly, with shipping included. Titrating up does not change your bill, which makes twelve-month budgeting genuinely possible.
Watch out for: The $79 membership is required, taking your real total to about $178/month. Mochi does not publicly name its compounding pharmacy.
Read the full Mochi Health review →Amazon One Medical
Why it's here: Clinical care and Amazon Pharmacy fulfillment in one company, built around the newly approved oral GLP-1 pills including Wegovy tablets. Consultations are $29 by message or $49 by video with no program subscription.
Watch out for: Higher doses are published at $299/month rather than $149. Minimal behavioral support, and a considerable amount of health data going to Amazon.
Read the full Amazon One Medical review →Success by Sesame
Why it's here: A cash-pay marketplace that publishes visit, subscription, and medication prices as separate line items, with labs and unlimited chat included in the subscription. Costco members get $29 visits and a $179 three-month starting subscription.
Watch out for: The number of published price points across Sesame and its partners makes it genuinely hard to work out your own total. Confirm at checkout.
Read the full Success by Sesame review →Lemonaid Health
Why it's here: A $49/month membership with no long-term commitment required is rare in a market built on 3, 6, and 12-month plans. Carries brand-name Ozempic, Wegovy, and Zepbound vials alongside compounded semaglutide.
Watch out for: Compounded semaglutide starting at $299/month is high relative to flat-rate competitors. Promotional rates like the advertised "$129/mo" come and go.
Read the full Lemonaid Health review →The Three Forms of Semaglutide
Before comparing providers, it helps to know which product you are actually shopping for, because they are priced and regulated very differently.
| Form | FDA status | Typical published cost | Where to get it |
|---|---|---|---|
| Wegovy pen (injection) | Approved for chronic weight management | $199/mo self-pay via NovoCare; copays vary with insurance | NovoCare, Walgreens, CVS, Amazon, any telehealth prescriber |
| Wegovy tablet (oral) | Approved late 2025, launched January 2026 | $149/mo self-pay via NovoCare; from $25/mo with insurance via Amazon | NovoCare, Amazon One Medical, Walgreens, Sesame |
| Compounded semaglutide | Not FDA-approved; shortage-era compounding window closed in 2025 | $70–$299/mo medication, usually plus a membership fee | Alloy, Mochi, Eden, Ivím, TrimRx, Henry, Brello, CoreAge RX |
| Ozempic | Approved for type 2 diabetes — off-label for weight loss | $149/mo pill, $199/mo pen self-pay via NovoCare | NovoCare, retail pharmacies, telehealth prescribers |
Should You Still Choose Compounded Semaglutide?
For two years the answer was obviously yes, because brand-name semaglutide cost over a thousand dollars a month and compounded versions cost a couple of hundred. That gap has narrowed dramatically.
Run the arithmetic on your own situation. Mochi at $79 membership plus $99 medication is $178/month. Eden at a reported $99 membership plus $99 medication is around $198/month. NovoCare's Wegovy pill is $149/month for an FDA-approved product with no membership at all. Compounded medication still wins at the very bottom of the range — Alloy's $70 medication price, for instance — but it is no longer a landslide.
There are still real reasons to choose compounded: providers who offer doses between the standard steps, people who want a microdose, and anyone whose prescriber has a specific clinical reason. But “it's the only affordable option” is no longer one of them.
What compounded actually means now
- The FDA declared the semaglutide shortage resolved in February 2025.
- 503A compounding pharmacies had until April 22, 2025 to stop compounding semaglutide; 503B outsourcing facilities had until May 22, 2025.
- Companies still offering compounded semaglutide generally frame it as a patient-specific personalized formulation — a microdose, or semaglutide combined with a vitamin such as B12 or B6.
- That practice sits in a contested legal area and the FDA has signaled further action.
- Compounded medication is not FDA-approved, is never covered by insurance, and has not been through the same review as the brand-name product.
Frequently Asked Questions
Who has the cheapest semaglutide?
For brand-name semaglutide, NovoCare Pharmacy publishes the Wegovy pill at $149/month and the Wegovy pen at $199/month self-pay, and its price guide states patients pay $149 for each month of the 1.5mg and 4mg doses. For compounded semaglutide, Alloy publishes medication from $70/month (plus $99/month care) and Mochi Health publishes $99/month for all doses (plus a $79/month membership).
Is compounded semaglutide still available in 2026?
Many telehealth companies still offer it, but the landscape changed. The FDA declared the semaglutide shortage resolved in February 2025, and the window for compounders to produce copies closed in April 2025 for 503A pharmacies and May 2025 for 503B outsourcing facilities. Companies that continue to offer it generally do so as patient-specific personalized formulations — often microdoses or versions combined with a vitamin. That practice remains legally contested.
What is the Wegovy pill?
Oral semaglutide 25mg, approved by the FDA at the end of 2025 as the first oral GLP-1 for chronic weight management, and launched in the US in early January 2026. It comes in 1.5mg, 4mg, 9mg, and 25mg tablet strengths. In the OASIS 4 trial, mean body weight change at 64 weeks was -13.6% versus -2.2% on placebo. Novo publishes it at $149/month self-pay through NovoCare Pharmacy.
Is Ozempic the same as Wegovy?
Both are semaglutide made by Novo Nordisk, but they are approved for different things and dosed differently. Ozempic is approved for type 2 diabetes; Wegovy is approved for chronic weight management. Prescribing Ozempic for weight loss is off-label use. We cover this in detail in our guide to whether semaglutide is the same as Ozempic.
Related Reading
- Semaglutide vs tirzepatide — which molecule, and why it matters more than which provider
- Complete semaglutide guide — how it works, dosing, and what trials found
- Best compounded GLP-1 providers — if compounded is what you want
- What GLP-1s actually cost — every pricing route in one place
Medical Disclaimer
We're not doctors, and this article is for education only — it isn't medical advice. GLP-1 medications are prescription-only and require evaluation by a licensed healthcare provider. Individual results vary widely, and only a clinician who knows your history can determine what is safe and appropriate for you. See our full medical disclaimer.
Keep Comparing
Every provider we've researched, with published pricing, medication type, and what's actually included.
Affiliate Disclosure: This article may contain affiliate links. If you sign up through one, we may earn a commission at no additional cost to you. We do not accept payment for favorable coverage. Read our full affiliate disclosure policy.